More Questions Raised Over Tamiflu
The race to be the world's anti-influenza drug leader continues to heat up, with Biota's Relenza receiving a leg up in light of a new study that is questioning the effectiveness...To view the full article, register now.
Already a subscriber? Click here to view full article